France· FR:67693946
AKYNZEO 300 mg/0,5 mg, gélules
A medicinal product, registered in France by HELSINN BIREX PHARMACEUTICALS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- HELSINN BIREX PHARMACEUTICALS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930038628plaquette(s) aluminium de 1 gélule(s)EUR 54.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
AKYNZEO in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandAkynzeoHelsinn Birex Pharmaceuticals Ltd.*
- CzechiaAKYNZEOHelsinn Birex Pharmaceuticals Ltd., Dublin
- NetherlandsAkynzeo 300 mg/0,5 mg harde capsulesHelsinn Birex Pharmaceuticals Limited
- PolandAkynzeoHelsinn Birex Pharmaceuticals Ltd.
- FinlandAkynzeoHelsinn Birex Pharmaceuticals Ltd
- SpainAKYNZEO 300 MG/0,5 MG CAPSULAS DURASHelsinn Birex Pharmaceuticals Limited
- United StatesAKYNZEOHelsinn Therapeutics (U.S.), Inc.
- SwitzerlandAkynzeo
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Akynzeo
- Liechtenstein · Akynzeo
- Norway · Akynzeo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cca39a11-a52e-46a1-96bf-3172ebcaced9 GET /v1/drugs/cca39a11-a52e-46a1-96bf-3172ebcaced9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67693946",
"date_amm": "2015-05-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1001",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about AKYNZEO.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.